Cargando…

Preliminary pharmaceutical development of antimalarial–antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas

Artemether (AM) plus azithromycin (AZ) rectal co-formulations were studied to provide pre-referral treatment for children with severe febrile illnesses in malaria-endemic areas. The target profile required that such product should be cheap, easy to administer by non-medically qualified persons, rapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaubert, Alexandra, Kauss, Tina, Marchivie, Mathieu, Ba, Boubakar B., Lembege, Martine, Fawaz, Fawaz, Boiron, Jean-Michel, Lafarge, Xavier, Lindegardh, Niklas, Fabre, Jean-Louis, White, Nicholas J., Olliaro, Piero L., Millet, Pascal, Gaudin, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier/North-Holland Biomedical Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045394/ https://www.ncbi.nlm.nih.gov/pubmed/24726300 http://dx.doi.org/10.1016/j.ijpharm.2014.04.023

Ejemplares similares

Pharmaceutical development and optimization of azithromycin suppository for paediatric use
por: Kauss, Tina, et al.
Publicado: (2013)

Screening paediatric rectal forms of azithromycin as an alternative to oral or injectable treatment
por: Kauss, Tina, et al.
Publicado: (2012)

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership
por: Lacaze, Catherine, et al.
Publicado: (2011)

Correction: Nguyen et al. Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria. Pharmaceutics 2022, 14, 299
por: Nguyen, Phuoc Vinh, et al.
Publicado: (2022)

Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria
por: Nguyen, Phuoc Vinh, et al.
Publicado: (2022)

Development of NIRS method for quality control of drug combination artesunate–azithromycin for the treatment of severe malaria
por: Boyer, Chantal, et al.
Publicado: (2012)

World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology
por: Barnes, Karen I, et al.
Publicado: (2007)

Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy
por: Davis, Mollie S, et al.
Publicado: (2019)

Cotherapy of Tiron and selenium against vanadium induced toxic effects in lactating rats
por: Shrivastava, Sadhana, et al.
Publicado: (2011)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

Benefits of a Pharmacology Antimalarial Reference Standard and Proficiency Testing Program Provided by the Worldwide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2014)

Assay for screening for six antimalarial drugs and one metabolite using dried blood spot sampling, sequential extraction and ion-trap detection
por: Blessborn, Daniel, et al.
Publicado: (2010)

Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleeding
por: Chaiyana, Parata, et al.
Publicado: (2023)

Could Mesna and Celery Seed Cotherapy Modulate Oxidative Stress and Inflammation of the Urinary Bladder Induced by Ifosfamide in Rabbits?
por: Mousa, Ayman M, et al.
Publicado: (2021)

Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease
por: Cococcioni, Lucia, et al.
Publicado: (2022)

Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)
por: Kindermans, Jean-Marie, et al.
Publicado: (2007)

Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis
por: Kauss, Tina, et al.
Publicado: (2008)

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
por: Lourens, Chris, et al.
Publicado: (2010)

Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study
por: Wang, Mei, et al.
Publicado: (2022)

Spectrophotometric Determination of Alfuzosin HCl in Pharmaceutical Formulations with some Sulphonephthalein Dyes
por: Ashour, Safwan, et al.
Publicado: (2006)

Geometric least squares means ratios for the analysis of Plasmodium falciparum in vitro susceptibility to antimalarial drugs
por: Vaillant, Michel, et al.
Publicado: (2007)

Gas chromatographic method for the determination of lumefantrine in antimalarial finished pharmaceutical products
por: Suleman, Sultan, et al.
Publicado: (2015)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Surveillance of Travellers: An Additional Tool for Tracking Antimalarial Drug Resistance in Endemic Countries
por: Gharbi, Myriam, et al.
Publicado: (2013)

Safety of antimalarial medications for use while scuba diving in malaria Endemic Regions
por: Petersen, Kyle, et al.
Publicado: (2016)

PTH/SDF-1α cotherapy induces CD90+CD34− stromal cells migration and promotes tissue regeneration in a rat periodontal defect model
por: Wang, Fang, et al.
Publicado: (2016)

Pregnancy Exposure Registries for Assessing Antimalarial Drug Safety in Pregnancy in Malaria-Endemic Countries
por: Dellicour, Stephanie, et al.
Publicado: (2008)

Quality of antimalarials in Kinshasa peri-urban areas with regard to local pharmaceutical legislation and regulation
por: Mavungu Landu, Don Jethro, et al.
Publicado: (2019)

A green compliant hand-held selective electrode device for monitoring active pharmaceuticals and the kinetics of their degradation
por: Badr ElDin, Norhan, et al.
Publicado: (2023)

Stromal cell‐derived factor‐1/Exendin‐4 cotherapy facilitates the proliferation, migration and osteogenic differentiation of human periodontal ligament stem cells in vitro and promotes periodontal bone regeneration in vivo
por: Liang, Qianyu, et al.
Publicado: (2021)

Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries
por: Palafox, Benjamin, et al.
Publicado: (2016)

Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes
por: Lo, Eugenia, et al.
Publicado: (2017)

Antimalarial procurement in private-sector pharmaceutical outlets: decision-making complexities and implications for medicine quality in Tanzania
por: Mshana, Gerry, et al.
Publicado: (2023)

Clinical Research and the Training of Host Country Investigators: Essential Health Priorities for Disease-Endemic Regions
por: Koita, Ousmane A., et al.
Publicado: (2016)

AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial
por: Koita, Ousmane A, et al.
Publicado: (2017)

Antimalarial drug use in general populations of tropical Africa
por: Gardella, Florence, et al.
Publicado: (2008)

Developing regional weight-for-age growth references for malaria-endemic countries to optimize age-based dosing of antimalarials
por: Hayes, Daniel J, et al.
Publicado: (2015)

Randomized Dose-Ranging Controlled Trial of AQ-13, a Candidate Antimalarial, and Chloroquine in Healthy Volunteers
por: Mzayek, Fawaz, et al.
Publicado: (2007)

Expanding the antimalarial toolkit: Targeting host–parasite interactions
por: Langhorne, Jean, et al.
Publicado: (2016)

Transport and pharmacodynamics of albitiazolium, an antimalarial drug candidate
por: Wein, S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bsdn59fsj4uf1g6efnbmo6ccna